To address whether USP1 and TAZ could be used as markers for the prognosis of breast cancer patients, we used gene set enrichment analysis (GSEA) and immunohistochemistry (IHC) staining of TNBC cases. This evidence concerns the gene USP1 and breast carcinoma.